Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15555 | 635 | 27.4 | 59% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2999 | 2103 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VINFLUNINE | Author keyword | 54 | 66% | 8% | 50 |
2 | VINCA ALKALOIDS | Author keyword | 5 | 19% | 4% | 23 |
3 | ONCOL PHARMACOKINET | Address | 4 | 67% | 1% | 4 |
4 | NAVELBINE | Author keyword | 3 | 26% | 2% | 11 |
5 | CATHARANTHUS ALKALOIDS | Author keyword | 3 | 100% | 0% | 3 |
6 | VINCA ALKALOID | Author keyword | 3 | 22% | 2% | 13 |
7 | MED CHEM 5 | Address | 3 | 60% | 0% | 3 |
8 | ANTI VASCULAR EFFECTS | Author keyword | 2 | 67% | 0% | 2 |
9 | DESACETYLVINBLASTINE | Author keyword | 2 | 67% | 0% | 2 |
10 | IN VITRO SENSITIVITY TESTING | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VINFLUNINE | 54 | 66% | 8% | 50 | Search VINFLUNINE | Search VINFLUNINE |
2 | VINCA ALKALOIDS | 5 | 19% | 4% | 23 | Search VINCA+ALKALOIDS | Search VINCA+ALKALOIDS |
3 | NAVELBINE | 3 | 26% | 2% | 11 | Search NAVELBINE | Search NAVELBINE |
4 | CATHARANTHUS ALKALOIDS | 3 | 100% | 0% | 3 | Search CATHARANTHUS+ALKALOIDS | Search CATHARANTHUS+ALKALOIDS |
5 | VINCA ALKALOID | 3 | 22% | 2% | 13 | Search VINCA+ALKALOID | Search VINCA+ALKALOID |
6 | ANTI VASCULAR EFFECTS | 2 | 67% | 0% | 2 | Search ANTI+VASCULAR+EFFECTS | Search ANTI+VASCULAR+EFFECTS |
7 | DESACETYLVINBLASTINE | 2 | 67% | 0% | 2 | Search DESACETYLVINBLASTINE | Search DESACETYLVINBLASTINE |
8 | IN VITRO SENSITIVITY TESTING | 2 | 67% | 0% | 2 | Search IN+VITRO+SENSITIVITY+TESTING | Search IN+VITRO+SENSITIVITY+TESTING |
9 | MO4 CELLS | 2 | 67% | 0% | 2 | Search MO4+CELLS | Search MO4+CELLS |
10 | VINDESINE | 2 | 12% | 2% | 14 | Search VINDESINE | Search VINDESINE |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NAVELBINE | 23 | 27% | 12% | 74 |
2 | 5 NOR | 22 | 81% | 2% | 13 |
3 | VINCA ALKALOIDS | 16 | 20% | 11% | 70 |
4 | INVITRO PHARMACOKINETICS | 11 | 100% | 1% | 6 |
5 | EXPERIMENTAL ANTITUMOR ACTIVITY | 11 | 69% | 1% | 9 |
6 | 5 NORANHYDROVINBLASTINE | 11 | 78% | 1% | 7 |
7 | 20 20 DIFLUORO 3 4 DIHYDROVINORELBINE | 9 | 83% | 1% | 5 |
8 | INTRAVENOUS BOLUS INJECTIONS | 8 | 100% | 1% | 5 |
9 | VINCAALKALOIDS | 8 | 100% | 1% | 5 |
10 | VINDESINE SULFATE | 6 | 80% | 1% | 4 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid | 2011 | 8 | 28 | 68% |
Vinflunine, the latest Vinca alkaloid in clinical development - A review of its preclinical anticancer properties | 2001 | 85 | 42 | 43% |
New Anticancer Agents: Recent Developments in Tumor Therapy | 2012 | 25 | 74 | 14% |
Clinical pharmacokinetics of vinorelbine | 1996 | 50 | 67 | 66% |
PHARMACOLOGY, BIOANALYSIS AND PHARMACOKINETICS OF THE VINCA ALKALOIDS AND SEMISYNTHETIC DERIVATIVES (REVIEW) | 1992 | 40 | 92 | 71% |
VINORELBINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL USE IN CANCER-CHEMOTHERAPY | 1994 | 54 | 64 | 45% |
High-performance liquid chromatography coupled with mass spectrometry for the quantitative analysis of vinca-alkaloids in biological matrices: a concise survey from the literature | 2010 | 6 | 31 | 52% |
Pharmacokinetics, metabolites, and preclinical safety of vinflunine | 2008 | 7 | 30 | 60% |
Vinorelbine in Cancer Therapy | 2012 | 7 | 27 | 26% |
Pharmacology of Catharanthus alkaloids. | 1996 | 28 | 71 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCOL PHARMACOKINET | 4 | 67% | 0.6% | 4 |
2 | MED CHEM 5 | 3 | 60% | 0.5% | 3 |
3 | EXPT CANC 1 | 1 | 100% | 0.3% | 2 |
4 | QUAL CONTROL ANALYT | 1 | 100% | 0.3% | 2 |
5 | CANCEROL EXPT 1 | 1 | 40% | 0.3% | 2 |
6 | ANALYT PHARMACOKINET S | 1 | 50% | 0.2% | 1 |
7 | BREAST CEPO | 1 | 50% | 0.2% | 1 |
8 | HLTH CARE BUSINESS | 1 | 50% | 0.2% | 1 |
9 | MED HEMATOL ONCOL SECT MED | 1 | 50% | 0.2% | 1 |
10 | ONCOL CLIN PHARMACOKINET | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000145756 | METASTATIC BREAST CANCER//VINORELBINE//DOCETAXEL |
2 | 0.0000132328 | INTRATHECAL VINCRISTINE//METHYLTHIONINIUM CHLORIDE//METABOLIC ENHANCER |
3 | 0.0000095175 | VINORELBINE//GEMCITABINE//ADVANCED NON SMALL CELL LUNG CANCER |
4 | 0.0000078878 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//GOSHAJINKIGAN//CIPN |
5 | 0.0000071204 | ASPIDOPHYTINE//ASPIDOSPERMA ALKALOIDS//STRYCHNOS ALKALOIDS |
6 | 0.0000066154 | TUMOR CELL MOTILITY//ANTI METASTATIC TREATMENT//ANTIMETASTATIC TREATMENT |
7 | 0.0000054164 | ETOPOSIDE PHOSPHATE//ETOPOSIDE//ORAL ETOPOSIDE |
8 | 0.0000052506 | METRONOMIC CHEMOTHERAPY//METRONOMIC//LOW DOSE METRONOMIC CHEMOTHERAPY |
9 | 0.0000051357 | CELL AND TISSUE KINETICS//CELL TUMOUR BIOL//H 3 DT |
10 | 0.0000049045 | CATHARANTHUS ROSEUS//TRYPTOPHAN DECARBOXYLASE//TERPENOID INDOLE ALKALOIDS |